Skip to content

GORE EXCLUDER AAA Endoprosthesis with C3 Delivery RMT261412Recalls & reported problems

W. L. Gore & Associates, Inc. · Class 3 · Implant

All models of GORE EXCLUDER AAA Endoprosthesis with C3 Delivery (51)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
4
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00733132610624), received between Jun 6, 2019 and Dec 6, 2023 — classified as 4 injuries.

The most frequently reported specific device problem is “Fluid/Blood Leak” (1 report).

2 other recalls cover devices cleared under the same FDA submission (P020004); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 1 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Fluid/Blood Leak1
  • Patient-Device Incompatibility1

Patient problems

  • Aneurysm1
  • Clinical Endoleak1
  • No Code Available1
  • Occlusion1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 6, 2023Fluid/Blood Leak; Fluid/Blood Leak

    ON (B)(6) 2014, THIS PATIENT UNDERWENT ENDOVASCULAR TREATMENT FOR AN ABDOMINAL AORTIC ANEURYSM MEASURING 54MM IN DIAMETER AND WAS IMPLANTED WITH GORE® EXCLUDER® AAA ENDOPROSTHESES. THE PATIENT TOLERATED THE PROCEDURE AND WAS DISCHARGED FROM THE HOSPITAL ON (B)(6), 2014. ON MARCH 4, 2015, THE PATIENT UNDERWENT FOLLOW-UP COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA) WHICH DETERMINED THE MAXIMUM DIAMETER OF THE AORTIC ANEURYSM/LESION MEASURED 51MM. ON FEBRUARY 8, 2022, THE PATIENT UNDERWENT FOLLOW-UP ULTRASOUND WHICH DETERMINED THE MAXIMUM DIAMETER OF THE AORTIC ANEURYSM/LESION MEASURED 49MM AND A TYPE II ENDOLEAK, NOT RELATED TO DEVICE OR PROCEDURE. ON OCTOBER 25, 2023, THE PATIENT UNDERWENT FOLLOW-UP ULTRASOUND WHICH DETERMINED THE MAXIMUM DIAMETER OF THE AORTIC ANEURYSM/LESION MEASURED 56MM. ON (B)(6), 2023, THE PATIENT UNDERWENT REINTERVENTION THIS DATE AND EMBOLIZATION A LUMBAR ARTERY THE ENDOLEAK WAS PERFORMED. THE PATIENT TOLERATED THE PROCEDURE AND WAS DISCHARGED TO HOME ON (B)(6) 2023. EMBOLIZATION RESOLVED THE ENDOLEAK.

    Patient problems: Clinical Endoleak

    MAUDE report 18276854 ↗
  • InjuryOct 5, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE PATIENT PRESENTED ON (B)(6) 2013, WITH A ABDOMINAL AORTIC ANEURYSM (DIAMETER 59 MM) AND BILATERAL COMMON ILIAC ANEURYSMS THAT WERE TREATED WITH GORE® EXCLUDER® AAA AND ENDOPROSTHESES AND GORE® EXCLUDER® ILIAC BRANCH (IBE) ENDOPROSTHESES. ON (B)(6) 2014, A TYPE II ENDOLEAK WAS IDENTIFIED. THE PATIENT WAS MONITORED THE FOLLOWING YEARS AND CONTINUOUS GROWTH TO 82 MM WAS VISIBLE. THE ENDOLEAK WAS SUCCESSFULLY TREATED WITH COILING ON (B)(6) 2020. THE PATIENT TOLERATED THE PROCEDURE.

    Patient problems: Aneurysm

    MAUDE report 10625332 ↗
  • InjuryFeb 21, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT ON (B)(6) 2010, THE PATIENT PRESENTED WITH AN ABDOMINAL AORTIC ANEURYSM THAT WAS TREATED WITH GORE® EXCLUDER® AAA ENDOPROSTHESES. ON (B)(6) 2019, AN ANEURYSM OF THE LEFT COMMON ILIAC ARTERY WAS IDENTIFIED. THE ANEURYSM WAS TREATED WITH AN EXTENSION OF THE PREVIOUSLY IMPLANTED GORE® EXCLUDER® TRUNK-IPSILATERAL LEG ENDOPROSTHESIS (RLT) ON (B)(6) 2020. THE PATIENT TOLERATED THE PROCEDURE.

    Patient problems: No Code Available

    MAUDE report 9738063 ↗
  • InjuryJun 6, 2019Patient-Device Incompatibility; Patient-Device Incompatibility

    ON (B)(6) 2013, THIS PATIENT UNDERWENT ENDOVASCULAR REPAIR OF AN ABDOMINAL AORTIC ANEURYSM USING A GORE EXCLUDER AAA ENDOPROSTHESIS. ON (B)(6) 2019, THE PATIENT PRESENTED TO THE HOSPITAL WITH LOWER EXTREMITY PAIN. COMPUTED TOMOGRAPHY REVEALED THAT THE PROXIMAL END OF THE TRUNK-IPSILATERAL LEG COMPONENT WAS COMPRESSED DUE TO A PREVIOUSLY UNDIAGNOSED THORACIC AORTIC DISSECTION. THE FALSE LUMEN EXTENDED INTO THE ABDOMINAL AORTA AND COMPRESSED THE TRUE LUMEN. THE PHYSICIAN THEREFORE IMPLANTED A GORE TAG THORACIC ENDOPROSTHESIS (TGU343415) TO TREAT THE DISSECTION. THE FALSE LUMEN WAS CLOSED, AND PERFUSION WAS RESTORED TO THE TRUE LUMEN, AND THE TRUNK-IPSILATERAL LEG COMPONENT FULLY EXPANDED. THE PATIENT TOLERATED THE PROCEDURE.

    Patient problems: Occlusion

    MAUDE report 8676208 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P020004. One submission often covers many models, so check the product and lot details in each record.

  • Z-0995-2020 · Jan 6, 2020 · Terminated
    GORE EXCLUDER AAA Endoprosthesis
  • Z-0996-2020 · Jan 6, 2020 · Terminated
    GORE EXCLUDER Iliac Branch Endoprosthesis (IBE)

Other System, Endovascular Graft, Aortic Aneurysm Treatment devices

All System, Endovascular Graft, Aortic Aneurysm Treatment devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page